ASAmina M. Salama

Amina M. Salama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amina M. Salama has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of the potential beneficial effects of Moringa oleifera on experimental Trichinella spiralis infection

    by Amina M. Salama, Dina I. Elgendy, Mahmoud S. Sharaf, Heba M. Shoeib, Mona M. Elwan, Wesam M. A. Elgendy

  • Effect of Irradiated Toxocara Canis Embryonated Eggs: A Promising Vaccination Strategy

    by Shreen F. Ammar, Sanaa N. Antonios, Rasha A. Elmahy, Radwa Ismail, Amina M. Salama

    Toxocariasis is a global zoonotic parasitic disease caused by Toxocara canis that poses significant public health challenges. The development of a vaccine would provide a promising method to control toxocariasis. This study aimed to evaluate the protective efficacy of gamma‐ and UV‐irradiated embryonated T. canis eggs in mice. Seventy Swiss albino mice were classified into four groups: Group (I) the normal control; Group (II) was subdivided into a positive control once (IIA) and positive control twice (IIB); Group (III) was subdivided into a gamma‐vaccinated control (IIIA) and gamma‐vaccinated challenged (IIIB); and Group (IV) was subdivided into a UV‐vaccinated control (IVA) and UV‐vaccinated challenged (IVB). On the 28th day post‐infection (dpi), scanning electron microscopy, parasitological, histopathological, immunohistochemical and biochemical analyses were performed. Larval counts in the brains and livers of vaccinated mice were significantly decreased. Compared to the positive control groups, vaccinated groups exhibited fewer histopathological alterations, a reduced immunohistochemical expression of IL‐1β in the brain and CD68 in the liver, and lower IL‐4, IL‐10 and IgE levels in both the gamma‐ and UV‐vaccinated challenged groups. Among the two approaches, the UV‐irradiated vaccine demonstrated superior protective effects. These findings suggest that vaccination with irradiated T. canis eggs, particularly with UV treatment, is a safe, efficient and cost‐effective method for immunoprophylaxis against human toxocariasis.

  • Open Access

    The potential relationship between Toxocara canis infection and epilepsy in a rat model

    by Amina M. Salama, Dina I. Elgendy, Rasha A. Elmahy, Asmaa F. Eltantawy, Monira A. Seleem, Ahmed M. Elgohary, Omaima K. Docmac, Marwa E. F. Al Mwafy, Ahmed A. Almeldin, Mahmoud S. Sharaf

    Human toxocariasis presents in several forms, including visceral larva migrans, ocular larva migrans, covert toxocariasis, and neurotoxocariasis. Although several studies suggest a potential link between toxocariasis and epilepsy, this link is still debated. Additional mechanistic and experimental studies in animal models are essential for a better understanding of this association. Our study aimed to explore the relationship between neurotoxocariasis and epilepsy in an animal model. In this study, 24 male Swiss albino rats were used. Rats were randomly assigned to three groups of eight: group I (normal control), group II (received pilocarpine hydrochloride in a single dose of 400 mg/kg body), and group III (infected with Toxocara canis). Several parameters were used to evaluate the possible link between toxocariasis and epilepsy, including clinical, histopathological, immunohistochemical, and biochemical studies. All rats in group III exhibited motor seizures 10 to 15 days post-infection, with no significant difference noticed regarding the maximum stage of seizures when compared with group II. Our study revealed definite structural and functional changes in the brain tissue, evidenced by the recorded histopathological changes, the increased GFAP, MMP2, and TNF-α expression, and the significant disturbances in neurotransmitter profile. Furthermore, a state of oxidative stress was noticed, with a significant increase in serum IL-6 levels. Our results indicate that the migration of Toxocara canis larvae to the central nervous system can result in significant structural changes and shifts in neurotransmitter levels, both of which may play a role in the development of epilepsy. Additionally, this research underscores the importance of oxidative stress and inflammatory cytokines in contributing to neuronal damage. These findings open avenues for future research aimed at identifying possible therapeutic targets and interventions to alleviate the neurological effects of toxocariasis. Graphical abstract


  • Trichinella spiralis Larval Extract as a Biological Anti‐Tumor Therapy in a Murine Model of Ehrlich Solid Carcinoma

    by Salwa S. Younis, Amina M. Salama, Dalia A. Elmehy, Nehal A. Heabah, Hanem M. Rabah, Sara H. Elakshar, Radwa A. Awad, Ghada A. Gamea

    Trichinella spiralis (T. spiralis) is an immunomodulating parasite that can adversely affect tumor growth and extend host lifespan. The aim of this study was to elucidate the mechanisms by which T. spiralis larval antigens achieve this effect using Ehrlich solid carcinoma (ESC) murine model. Assessment was done by histopathological and immunohistochemical analysis of caspase‐3, TNF‐α, Ki‐67 and CD31. Additionally, Bcl2 and Bcl2‐associated protein X (Bax) relative gene expression was assessed by molecular analysis for studying the effect of T. spiralis crude larval extract (CLE) antigen on tumor necrosis, apoptosis, cell proliferation and angiogenesis. We found that both T. spiralis infection and CLE caused a decrease in the areas of necrosis in ESC. Moreover, they led to increased apoptosis through activation of caspase‐3, up‐regulation of pro‐apoptotic gene, Bax and down‐regulation of anti‐apoptotic gene, Bcl2. Also, T. spiralis infection and CLE diminished ESC proliferation, as evidenced by decreasing Ki‐67. T. spiralis infection and CLE were able to suppress the development of ESC by inhibiting tumor proliferation, inducing apoptosis and decreasing tumor necrosis, with subsequent decrease in tumor metastasis. T. spiralis CLE antigen may be considered as a promising complementary immunotherapeutic agent in the treatment of cancer.


  • Efficacy of artemether against toxocariasis in mice: parasitological and immunopathological changes in brain, liver, and lung

    by Dina I. Elgendy, Rasha A. Elmahy, Alaa Ibrahim Mohamed Amer, Hoda A. Ibrahim, Asmaa Fawzy Eltantawy, Fotouh Rashed Mansour, Amina M. Salama

    Toxocariasis is a zoonosis that represents a serious threat to public health particularly in tropical and subtropical areas. Currently, albendazole, the most effective drug for treating visceral toxocariasis, shows moderate efficacy against the larvae in tissues and has some adverse effects. Artemether is an antiparasitic drug mainly used in the treatment of malaria and showed effectiveness against numerous helminthic infections. Besides, it possesses potent anti-inflammatory, antiapoptotic, antifibrotic, and neuroprotective properties. Thus, the study's aim was to investigate artemether's effects in comparison with albendazole on the therapeutic outcome of experimental toxocariasis. For this aim, 140 laboratory-bred mice were divided into four main groups: uninfected control, treatment control, albendazole-treated, and artemether-treated groups. The treatment regimens were started at the 15th dpi (early treatment), and at the 35th dpi (late treatment). The effectiveness of treatment was determined by brain larval count, histopathological, immunohistochemical, and biochemical examination. Artemether showed more effectiveness than albendazole in reducing brain larval counts, markers of brain injury including NF-κB, GFAP, and caspase-3, the diameter and number of hepatic granulomas, hepatic oxidative stress, hepatic IL-6, and TG2 mRNA, and pulmonary inflammation and fibrosis. The efficacy of artemether was the same when administered early or late in the infection. Finally, our findings illustrated that artemether might be a promising therapy for T. canis infection and it could be a good substitution for albendazole in toxocariasis treatment.


  • Open Access

    Effects of metformin on parasitological, pathological changes in the brain and liver and immunological aspects during visceral toxocariasis in mice

    by Amina M. Salama, Rasha A. Elmahy, Hoda A. Ibrahim, Alaa Ibrahim Mohamed Amer, Asmaa Fawzy Eltantawy, Dina I. Elgendy

    There are currently insufficient anthelmintic medications available for the treatment of toxocariasis. For instance, Albendazole (ABZ) is the preferred medication, but its effectiveness against tissue-dwelling parasites is limited. In addition, Metformin (MTF) is a widely used oral antidiabetic medication that is considered to be safe for treatment. This study aimed to investigate any potential effects of MTF, alone or in combination with ABZ, on mice infections caused by Toxocara canis (T. canis). The efficacy of the treatment was assessed in the acute and chronic phases of the infection by larval recovery and histopathological, immunohistochemical, and biochemical studies. The results showed that combined therapy significantly reduced larval counts in the liver, brain, and muscles and ameliorated hepatic and brain pathology. It reduced oxidative stress and TGF-β mRNA expression and increased FGF21 levels in the liver. It decreased TNF-α levels and MMP-9 expression in the brain. In addition, it increased serum levels of IL-12 and IFN-γ and decreased serum levels of IL-4 and IL-10. In the acute and chronic phases of the infection, the combined treatment was more effective than ABZ alone. In conclusion, this study highlights the potential role of MTF as an adjuvant in the treatment of experimental T. canis infection when administered with ABZ.